Eton Pharmaceuticals, Inc. Annual Depreciation in USD from 2018 to 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Eton Pharmaceuticals, Inc. quarterly/annual Depreciation history and growth rate from 2018 to 2023.
  • Eton Pharmaceuticals, Inc. Depreciation for the quarter ending June 30, 2024 was $12K, a 20% increase year-over-year.
  • Eton Pharmaceuticals, Inc. Depreciation for the twelve months ending June 30, 2024 was $47K, a 6% decline year-over-year.
  • Eton Pharmaceuticals, Inc. annual Depreciation for 2023 was $44K, a 33.3% decline from 2022.
  • Eton Pharmaceuticals, Inc. annual Depreciation for 2022 was $66K, a 57.4% decline from 2021.
  • Eton Pharmaceuticals, Inc. annual Depreciation for 2021 was $155K.
Depreciation, Trailing 12 Months (USD)
Depreciation, Annual (USD)
Depreciation, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $44K -$22K -33.3% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-14
2022 $66K -$89K -57.4% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-14
2021 $155K Jan 1, 2021 Dec 31, 2021 10-K 2024-03-14
2018 $51K Jan 1, 2018 Dec 31, 2018 10-K 2019-03-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.